Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sirolimus for treatment of steroid-refractory acute graft-versus-host disease.
Hoda D, Pidala J, Salgado-Vila N, Kim J, Perkins J, Bookout R, Field T, Perez L, Ayala E, Ochoa-Bayona JL, Raychaudhuri J, Alsina M, Greene J, Janssen W, Fernandez HF, Anasetti C, Kharfan-Dabaja MA. Hoda D, et al. Among authors: anasetti c. Bone Marrow Transplant. 2010 Aug;45(8):1347-51. doi: 10.1038/bmt.2009.343. Epub 2009 Dec 7. Bone Marrow Transplant. 2010. PMID: 19966849
Infliximab for managing steroid-refractory acute graft-versus-host disease.
Pidala J, Kim J, Field T, McBride A, Kharfan-Dabaja M, Perkins J, Fernandez H, Perez L, Ayala E, Anasetti C. Pidala J, et al. Among authors: anasetti c. Biol Blood Marrow Transplant. 2009 Sep;15(9):1116-21. doi: 10.1016/j.bbmt.2009.05.019. Biol Blood Marrow Transplant. 2009. PMID: 19660725 Free article.
Glucocorticoid-refractory acute graft-versus-host disease.
Pidala J, Anasetti C. Pidala J, et al. Among authors: anasetti c. Biol Blood Marrow Transplant. 2010 Nov;16(11):1504-18. doi: 10.1016/j.bbmt.2010.01.007. Epub 2010 Jan 21. Biol Blood Marrow Transplant. 2010. PMID: 20096359 Free article. Review.
A randomized phase II trial comparing tacrolimus and mycophenolate mofetil to tacrolimus and methotrexate for acute graft-versus-host disease prophylaxis.
Perkins J, Field T, Kim J, Kharfan-Dabaja MA, Fernandez H, Ayala E, Perez L, Xu M, Alsina M, Ochoa L, Sullivan D, Janssen W, Anasetti C. Perkins J, et al. Among authors: anasetti c. Biol Blood Marrow Transplant. 2010 Jul;16(7):937-47. doi: 10.1016/j.bbmt.2010.01.010. Epub 2010 Jan 25. Biol Blood Marrow Transplant. 2010. PMID: 20102746 Free article. Clinical Trial.
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.
Kharfan-Dabaja MA, Chavez JC, Yu D, Zhu W, Fernandez-Vertiz EI, Perkins J, Shapiro J, Bookout R, Perez L, Fernandez HF, Komrokji RS, Lancet J, Brand L, Field T, Ayala E, Janssen W, List AF, Anasetti C. Kharfan-Dabaja MA, et al. Among authors: anasetti c. Biol Blood Marrow Transplant. 2011 Mar;17(3):384-93. doi: 10.1016/j.bbmt.2010.07.011. Epub 2010 Jul 22. Biol Blood Marrow Transplant. 2011. PMID: 20655389 Free article.
437 results